AI for predicting brain cancer relapse represents a groundbreaking advancement in cancer care, particularly in pediatric patients facing gliomas.Recent studies highlight how artificial intelligence can outperform traditional methods by analyzing multiple brain scans over time to assess the risk of recurrence.